For following the competition: what moved in each program, several studies read as one move.
- GIPR Agonist LY3537021
- ADCX-020
- Tumor Associated Lymph node T cell
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Drug-Related Side Effects and Adverse Reactions to watchlistEvery Monday by email · turn it off any timePro · free during the beta